Finding a Genetic Marker for Leukemia Diagnosis, Prognosis, and Treatment | GenomeWeb

Acute lymphoblastic leukemia is a common childhood cancer that is known to be caused by a number of genetic alterations. Determining what those genetic alterations are at the time of diagnosis may be the key to deciding which treatments to use and determining the probability of patient relapse, says St. Jude Children's Research Hospital's Charles Mullighan. While he has conducted several studies on leukemia-associated mutations over the past several years, Mullighan has also begun to look into the nature of the cell population present in a patient at diagnosis and at relapse.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.